Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp, B. Daan Westenbrink, Wouter Ouwerkerk, et al.
Journal of the American College of Cardiology (2018) Vol. 72, Iss. 10, pp. 1081-1090
Open Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

Epidemiology of heart failure
Amy Groenewegen, Frans H. Rutten, Arend Mosterd, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 8, pp. 1342-1356
Open Access | Times Cited: 1451
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A. de Boer, et al.
European Heart Journal (2019) Vol. 40, Iss. 40, pp. 3297-3317
Open Access | Times Cited: 1322
Sex differences in heart failure
Carolyn S.P. Lam, Clare Arnott, A. Beale, et al.
European Heart Journal (2019) Vol. 40, Iss. 47, pp. 3859-3868c
Open Access | Times Cited: 581
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Circulation (2019) Vol. 140, Iss. 7
Open Access | Times Cited: 497
Evaluation and management of heart failure with preserved ejection fraction
Barry A. Borlaug
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 559-573
Closed Access | Times Cited: 480
Inflammation in Heart Failure
Sean Murphy, Rahul Kakkar, Cian P. McCarthy, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 11, pp. 1324-1340
Open Access | Times Cited: 447
Research Priorities for Heart Failure With Preserved Ejection Fraction
Sanjiv J. Shah, Barry A. Borlaug, Dalane W. Kitzman, et al.
Circulation (2020) Vol. 141, Iss. 12, pp. 1001-1026
Open Access | Times Cited: 326
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 3, pp. 391-412
Open Access | Times Cited: 302
Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial
Milton Packer, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 10, pp. 1270-1278
Open Access | Times Cited: 251
Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial
Stefan D. Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 10, pp. 1279-1287
Open Access | Times Cited: 223
From Systemic Inflammation to Myocardial Fibrosis
Walter J. Paulus, Michael R. Zile
Circulation Research (2021) Vol. 128, Iss. 10, pp. 1451-1467
Open Access | Times Cited: 214
Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis
Gregory Livshits, Alexander Kalinkovich
Ageing Research Reviews (2019) Vol. 56, pp. 100980-100980
Closed Access | Times Cited: 174
Metabolic inflammation in heart failure with preserved ejection fraction
Gabriele G. Schiattarella, Daniele Rodolico, Joseph A. Hill
Cardiovascular Research (2020) Vol. 117, Iss. 2, pp. 423-434
Open Access | Times Cited: 170
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction
Sandra Sanders‐van Wijk, Jasper Tromp, Lauren Beussink‐Nelson, et al.
Circulation (2020) Vol. 142, Iss. 21, pp. 2029-2044
Open Access | Times Cited: 160
Heart failure with preserved ejection fraction: everything the clinician needs to know
Patricia Campbell, Frans H. Rutten, Matthew M.Y. Lee, et al.
The Lancet (2024) Vol. 403, Iss. 10431, pp. 1083-1092
Closed Access | Times Cited: 53
Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development
Amil M. Shah, Peder L. Myhre, Victoria Arthur, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Journal of Cardiac Failure (2019) Vol. 25, Iss. 8, pp. 584-619
Closed Access | Times Cited: 121
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
John G.F. Cleland, João Pedro Ferreira, Beatrice Mariottoni, et al.
European Heart Journal (2020) Vol. 42, Iss. 6, pp. 684-696
Open Access | Times Cited: 121
Selenium and outcome in heart failure
Nils Bömer, Niels Grote Beverborg, Martijn F. Hoes, et al.
European Journal of Heart Failure (2019) Vol. 22, Iss. 8, pp. 1415-1423
Open Access | Times Cited: 120
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Domenico D’Amario, Stefano Migliaro, Josip A. Borovac, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 109
Role of Inflammatory Cell Subtypes in Heart Failure
Derek Strassheim, Edward C. Dempsey, Evgenia Gerasimovskaya, et al.
Journal of Immunology Research (2019) Vol. 2019, pp. 1-9
Open Access | Times Cited: 92
Macrophages in Heart Failure with Reduced versus Preserved Ejection Fraction
Matthew DeBerge, Sanjiv J. Shah, Lisa D. Wilsbacher, et al.
Trends in Molecular Medicine (2019) Vol. 25, Iss. 4, pp. 328-340
Open Access | Times Cited: 87
Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction
Thomas M. Gorter, Gijs van Woerden, Michiel Rienstra, et al.
JACC Heart Failure (2020) Vol. 8, Iss. 8, pp. 667-676
Open Access | Times Cited: 87
Acute heart failure
Lauren Sinnenberg, Michael M. Givertz
Trends in Cardiovascular Medicine (2019) Vol. 30, Iss. 2, pp. 104-112
Closed Access | Times Cited: 86
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure
João Pedro Ferreira, Job A.J. Verdonschot, Timothy Collier, et al.
Circulation Heart Failure (2019) Vol. 12, Iss. 5
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top